**2.5 Summary of the recommendations in categories included in the clinical practice guidelines**

After the quality assessment of each eligible CPGs, those who scored higher than 60% in 3 (rigor of development) and 6 (editorial independence) AGREE II domains were used to summarize the recommendations in categories included in the CPGs.

Two reviewers independently read each CPG to gain an overall knowledge of content and identify topics covered by the guidelines. The topics with the same theme were defined through constant comparison and were grouped within categories to contextualize the recommendations for pharmacological VTE prophylaxis. Generic recommendations were not included within the categories.
